儿童颅缝早闭手术中高剂量与低剂量氨甲环酸的比较:双盲随机对照非劣效性试验
结果显示低剂量组失血量非劣于高剂量组(差值0.9 ml kg-1,95%CI -14.2至15.9),输血量亦无显著差异。
要点
- 低剂量氨甲环酸在减少儿童颅缝早闭手术失血方面非劣于高剂量方案
- 两组输血量及纤溶、炎症生物标志物无显著差异,未观察到不良事件
- 低剂量方案为10 mg kg-1负荷后5 mg kg-1 h-1维持
核心结论
- 氨甲环酸10 mg kg-1后5 mg kg-1 h-1在减少儿童颅缝早闭手术失血和输血方面不劣于高剂量50 mg kg-1后5 mg kg-1 h-1方案。
主要发现
- 高剂量组(n=32)与低剂量组(n=34)失血量分别为39.4(4.4)与40.3(6.2)ml kg-1,差值0.9(95%CI -14.2至15.9),非劣效性成立。
- 输血量分别为21.3(1.6)与23.6(1.5)ml kg-1,差值2.3(95%CI -2.1至6.7)。
- 术中氨甲环酸血浆浓度平均分别为50.2(8.0)与29.6(7.6)μg ml-1。
- 纤溶和炎症生物标志物浓度无差异,未观察到不良事件。
关键数值与推荐
- 非劣效性界值为失血均数差值的95%CI下限高于-20 ml kg-1。
- 低剂量方案:10 mg kg-1负荷后5 mg kg-1 h-1维持;高剂量方案:50 mg kg-1负荷后5 mg kg-1 h-1维持。
临床怎么用
- 儿童颅缝早闭手术可考虑采用低剂量氨甲环酸方案(10 mg kg-1负荷后5 mg kg-1 h-1),在保证疗效的同时可能减少药物暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) reduces blood loss and transfusion in paediatric craniosynostosis surgery. The hypothesis is that low-dose TXA, determined by pharmacokinetic modelling, is non-inferior to high-dose TXA in decreasing blood loss and transfusion in children. METHODS: Children undergoing craniosynostosis surgery were enrolled in a two-centre, prospective, double-blind, randomised, non-inferiority controlled trial to receive high TXA (50 mg kg-1 followed by 5 mg kg-1 h-1) or low TXA (10 mg kg-1 followed by 5 mg kg-1 h-1). Primary outcome was blood loss. Low dose was determined to be non-inferior to high dose if the 95% confidence interval (CI) for the mean difference in blood loss was above the non-inferiority margin of -20 ml kg-1. Secondary outcomes were transfusion, TXA plasma concentrations, and biological markers of fibrinolysis and inflammation. RESULTS: Sixty-eight children were included. Values were non-inferior regarding blood loss (39.4 [4.4] vs 40.3 [6.2] ml kg-1 [difference=0.9; 95% CI: -14.2, 15.9]) and blood transfusion (21.3 [1.6] vs 23.6 [1.5] ml kg-1 [difference=2.3; 95% CI: -2.1, 6.7]) between high-dose (n=32) and low-dose (n=34) groups, respectively. The TXA plasma concentrations during surgery averaged 50.2 (8.0) and 29.6 (7.6) μg ml-1. There was no difference in fibrinolytic and inflammatory biological marker concentrations. No adverse events were observed. CONCLUSIONS: Tranexamic acid 10 mg kg-1 followed by 5 mg kg-1 h-1 is not less effective than a higher dose of 50 mg kg-1 and 5 mg kg-1 h-1 in reducing blood loss and transfusion in paediatric craniosynostosis surgery. CLINICAL TRIAL REGISTRATION: NCT02188576.
引用
- Goobie SM, Staffa SJ, Meara JG, et al. High-dose versus low-dose tranexamic acid for paediatric craniosynostosis surgery: a double-blind randomised controlled non-inferiority trial. Br J Anaesth. 2020. PMID: 32620262. doi:10.1016/j.bja.2020.05.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。